For PANC-1 pancreatic carcinoma cells, we discovered that stable expression of constitutive active EGFP-K-Ras(V12) decreased Rac1 and RhoA activity and increased p38 MAPK activity, which contributes to enhanced cell motility and invasiveness [21]. The gene discussed is KRAS; the disease is exocrine pancreatic carcinoma.